Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Chỉ hiển thị Multimedia

Canakinumab improves survival in advanced NSCLC
07 Oct 2023
bởiStephen Padilla
Treatment with canakinumab appears beneficial to patients with advanced nonsmall cell lung cancer (NSCLC) with low T-cell infiltration (ie, low total count or immune desert phenotype), results of predefined exploratory biomarker analyses from the CANOPY-1 have shown.
Canakinumab improves survival in advanced NSCLC
07 Oct 2023
Liraglutide vs semaglutide: Which is a better GLP-1 RA for diabetic veterans?
06 Oct 2023
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) liraglutide and semaglutide are both effective at lowering haemoglobin A1c (A1c) among veterans with type 2 diabetes mellitus (T2DM), reports a recent study, which provides insights into key considerations for this population.
Liraglutide vs semaglutide: Which is a better GLP-1 RA for diabetic veterans?
06 Oct 2023
Early use of DPP-4 inhibitors delays insulin initiation in Chinese T2D patients
06 Oct 2023
bởiKanas Chan
Early dipeptidyl peptidase 4 (DPP-4) inhibitor intensification delays insulin initiation in Chinese patients with type 2 diabetes (T2D), a cohort study in Hong Kong has shown.